StockWatch
·

KABRA DRUGS LTD. Q4 FY25 Results

KABRADGQ4 FY25 Results
Filing
MetricValue ( Cr)
Revenue0.00
Total Income0.64
Expenditure0.25
PBT0.39
Net Profit0.39
OPM
NPM61.50%
EPS0.21
View full financials

Informational and educational content only. Not investment advice.